GRIFOLS | GRF - Net Income


GRIFOLS reported EUR162M in Net Income for its fiscal quarter ending in September of 2026.





Net Income Change Date
Alcon AG USD 189M 28M Mar/2026
Almirall EUR 24.25M 4.68M Jun/2026
Amadeus IT EUR 381.8M 38.1M Sep/2026
Amarin USD -1.22M 6.51M Dec/2025
argenx SE USD 506M 34M Sep/2026
AstraZeneca USD 3.12B 610M Sep/2026
Bayer EUR -672M 891M Sep/2026
Cie Automotive EUR 149.91M 35.97M Dec/2025
Demant DKK 1.18B 758M Jun/2026
Ence Energia y Celulosa EUR 10.15M 27.75M Sep/2026
Essilor EUR 1.57B 638M Jun/2026
Ferrovial EUR 258M 90M Jun/2026
Fresenius EUR 371M 11M Sep/2026
Fresenius Medical Care EUR 160M 58.38M Sep/2026
Genmab DKK 303M 250M Jun/2026
GlaxoSmithKline GBP 1.54B 1.11B Sep/2026
GRIFOLS EUR 162M 8M Sep/2026
Hikma Pharmaceutical USD 164M 45M Dec/2025
Inditex EUR -1.37B 2.75B Jun/2026
Lakefront Biotherapeutics EUR 2.11M 12.38M Jun/2026
Merck EUR 490M 169M Jun/2026
Novartis USD 1.2B 2.06B Sep/2026
Philips EUR 27M 357M Sep/2026
Roche Holding CHF 6.87B 1.4B Jun/2026
Sanofi EUR 3.02B 2.68B Sep/2026
Smith & Nephew USD 303M 10M Jun/2026
UCB EUR 1.08B 608M Dec/2025
Viscofan EUR 40.44M 2.79M Sep/2026